Observational studyFrontiers in endocrinology2026
Mild autonomous cortisol secretion and brain function: cognitive, structural, and functional correlates.
Observational study in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Mild autonomous cortisol secretion (MACS) is increasingly recognized as a condition associated with subtle cognitive, functional, and clinical alterations, despite the absence of overt hypercortisolism. Its impact on brain function, sleep quality, and mood, however, remains incompletely understood. Objective: The aim of this observational, cross-sectional study was to investigate cognitive performance, sleep quality, mood, and structural and functional brain alterations in patients with MACS compared with those with non-functioning adrenal tumors (NFAT). Participants: Forty-eight patients with adrenal incidentalomas were enrolled, including 28 patients with MACS and 20 with NFAT, all without clinical signs of overt hypercortisolism at study entry. Methods: Participants had a confirmed failure to suppress cortisol on 1 mg of dexamethasone and underwent comprehensive neuropsychological testing, sleep quality assessment (PSQI), mood evaluation (BDI-II), and brain magnetic resonance imaging (MRI) including structural imaging, voxel-based morphometry, and resting-state functional MRI (fMRI). Results: Compared with patients with NFAT, those with MACS exhibited slightly lower Mini-Mental State Examination (MMSE) scores and poorer delayed verbal recall, both negatively correlated with serum cortisol levels. Patients with MACS also showed significantly poorer sleep quality, with MACS status and female sex emerging as independent predictors. No group differences were observed in depressive symptoms. Resting-state fMRI revealed altered hippocampal connectivity in MACS, with reduced connectivity with the caudate nucleus and increased connectivity with mesial occipital regions. Voxel-based morphometry showed no structural differences between groups. Conclusions: Even mild, clinically silent cortisol excess can be associated with subtle cognitive alterations, impaired sleep, and early functional connectivity changes, despite preserved brain morphology. Longitudinal studies are needed to determine whether these alterations progress over time and whether they improve with targeted treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.